Andreas Eckert
Clinical Researcher
Papers
Trials
Key Impact
Notable for contributions to controlled human experimental studies characterising acute effects, pharmacology and receptor mechanisms of serotonergic and entactogenic compounds.
Background & Research
Andreas Eckert is a clinical researcher active in experimental human psychopharmacology with a focus on acute-phase studies of classical psychedelics and entactogens. He has co‑authored multiple randomised, double‑blind, placebo‑controlled and crossover trials in healthy volunteers examining the acute subjective, physiological and receptor‑mediated effects of compounds including LSD, psilocybin, DMT and several MDMA variants. His work frequently appears in collaborations that probe dose‑responses, stereoisomer differences, drug–drug interactions (for example SSRI pretreatment) and the role of the 5‑HT2A receptor in mediating acute psychedelic effects.